公开(公告)号：US20170313766A1

公开(公告)日：2017-11-02

申请号：US15645399

申请日：2017-07-10

Applicant: AIMM THERAPEUTICS B.V.

Inventor： Hergen SPITS ,  Tim BEAUMONT ,  Mark Jeroen KWAKKENBOS ,  Arjen Quirinus BAKKER

IPC: C07K16/10 ,  G01N33/569 ,  A61K39/00

CPC classification number: C07K16/1018 ,  A61K2039/505 ,  C07K2317/21 ,  C07K2317/31 ,  C07K2317/33 ,  C07K2317/565 ,  C07K2317/76 ,  C07K2317/92 ,  G01N33/56983

Abstract: The invention relates to isolated, synthetic or recombinant antibodies and functional parts thereof specific for multiple influenza A virus subtypes. The invention further relates to the use of such antibodies for diagnosis of an influenza A virus infection and as a medicament and/or prophylactic agent for at least in part treating or alleviating symptoms of an influenza A virus infection.